Tianjin Ringpu Bio Tech Working Capital to Net Assets Ratio
Tianjin Ringpu Bio Tech working capital to net assets ratio. Tianjin Ringpu Bio Tech (300119) has a Working Capital to Net Assets ratio of 29.9% as of March 2026. Working capital of CN¥1.58 Billion (current assets of CN¥3.54 Billion minus current liabilities of CN¥1.96 Billion) is measured against net assets of CN¥5.27 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 300119 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tianjin Ringpu Bio Tech (2007–2025)
Working capital to net assets ratio of Tianjin Ringpu Bio Tech from 2007 to 2025. This chart shows how Tianjin Ringpu Bio Tech's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 29.9%, reflecting working capital of CN¥1.58 Billion against net assets of CN¥5.27 Billion CNY. See Tianjin Ringpu Bio Tech (300119) defensive interval to measure how many days the company can operate on defensive assets alone.
Tianjin Ringpu Bio Tech Working Capital to Net Assets Ratio by Year (2007–2025)
Tianjin Ringpu Bio Tech working capital to net assets ratio by year from 2007 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Tianjin Ringpu Bio Tech from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Tianjin Ringpu Bio Tech (300119) total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.6% | CN¥1.48 Billion | CN¥5.18 Billion | CN¥3.37 Billion | CN¥1.89 Billion | ▲ +0.7 pp |
| 2024 | 27.9% | CN¥1.40 Billion | CN¥5.01 Billion | CN¥3.65 Billion | CN¥2.25 Billion | ▼ -12.0 pp |
| 2023 | 39.9% | CN¥1.92 Billion | CN¥4.80 Billion | CN¥3.26 Billion | CN¥1.34 Billion | ▲ +0.3 pp |
| 2022 | 39.6% | CN¥1.78 Billion | CN¥4.50 Billion | CN¥3.09 Billion | CN¥1.31 Billion | ▼ -5.2 pp |
| 2021 | 44.8% | CN¥1.94 Billion | CN¥4.32 Billion | CN¥3.06 Billion | CN¥1.12 Billion | ▲ +18.2 pp |
| 2020 | 26.6% | CN¥727.57 Million | CN¥2.74 Billion | CN¥1.60 Billion | CN¥877.23 Million | ▲ +6.0 pp |
| 2019 | 20.6% | CN¥486.17 Million | CN¥2.36 Billion | CN¥1.53 Billion | CN¥1.05 Billion | ▼ -10.2 pp |
| 2018 | 30.9% | CN¥695.90 Million | CN¥2.25 Billion | CN¥1.36 Billion | CN¥665.46 Million | ▲ +0.5 pp |
| 2017 | 30.4% | CN¥661.12 Million | CN¥2.18 Billion | CN¥1.32 Billion | CN¥657.30 Million | ▼ -0.7 pp |
| 2016 | 31.1% | CN¥655.37 Million | CN¥2.11 Billion | CN¥1.17 Billion | CN¥518.07 Million | ▲ +8.2 pp |
| 2015 | 22.9% | CN¥405.50 Million | CN¥1.77 Billion | CN¥900.89 Million | CN¥495.39 Million | ▼ -18.5 pp |
| 2014 | 41.4% | CN¥715.17 Million | CN¥1.73 Billion | CN¥902.33 Million | CN¥187.16 Million | ▼ -8.6 pp |
| 2013 | 50.0% | CN¥860.86 Million | CN¥1.72 Billion | CN¥1.08 Billion | CN¥215.22 Million | ▼ -12.6 pp |
| 2012 | 62.6% | CN¥993.27 Million | CN¥1.59 Billion | CN¥1.15 Billion | CN¥153.50 Million | ▼ -14.7 pp |
| 2011 | 77.3% | CN¥1.16 Billion | CN¥1.50 Billion | CN¥1.31 Billion | CN¥153.20 Million | ▼ -5.7 pp |
| 2010 | 83.0% | CN¥1.18 Billion | CN¥1.43 Billion | CN¥1.37 Billion | CN¥183.90 Million | ▲ +41.5 pp |
| 2009 | 41.4% | CN¥104.65 Million | CN¥252.48 Million | CN¥254.98 Million | CN¥150.33 Million | ▼ -13.1 pp |
| 2008 | 54.5% | CN¥136.26 Million | CN¥249.97 Million | CN¥208.64 Million | CN¥72.38 Million | ▼ -2.0 pp |
| 2007 | 56.5% | CN¥77.02 Million | CN¥136.21 Million | CN¥116.48 Million | CN¥39.46 Million | — |